HIGHLIGHTS
- who: COPYRIGHT and collaborators from the University of Mississippi, United States have published the Article: Therapeutic potential of compounds targeting SARS-CoV-2 helicase, in the Journal: (JOURNAL) of 25/07/2022
- how: The best scoring helicase inhibitors resulting from in silico approach and without in_vitro data are shown in Supplementary Table S3.
SUMMARY
Concerns over renal toxicity (Gérard et_al, 2021; Wu et_al, 2022), as well as a cardiac safety signal (Rafaniello et_al, 2021) challenge the safety of the drug. The mechanism of action of molnupiravir is concerning as it . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.